Biopesticides: Why the U.S. and Brazil Are Becoming Key Markets for Global Manufacturers
Regulatory changes and growing demand are reshaping biological crop protection, with the U.S. and Brazil attracting international manufacturers.
The United States and Brazil are emerging as two strategic destinations for international biopesticide manufacturers, supported by large agricultural markets, established distribution networks and growing interest in biological crop protection. Brazil reported a record 162 registrations of products classified as biological inputs in 2025, according to its Ministry of Agriculture and Livestock (MAPA), while the U.S. Environmental Protection Agency (EPA) continues to evaluate biological pesticides under an established federal framework. At the same time, regulatory reforms in Argentina and other Latin American countries are reshaping opportunities for technology developers seeking access to regional markets.
The expansion of biological crop protection reflects growing interest in diversifying pest and disease management strategies. Microorganisms, biochemical substances, botanical extracts and other biological agents are being developed for agricultural applications. However, entering a new market involves more than demonstrating product efficacy. Manufacturers must determine the appropriate regulatory classification, provide safety information, validate agronomic performance and comply with national registration requirements. Approval in one country does not automatically authorize commercialization in another, even when products contain similar biological ingredients.
USDA researchers examine beneficial fungal cultures as the development of microbial biopesticides requires scientific validation, consistent formulations and compliance with agricultural regulations.
U.S. and Brazil Offer Major Opportunities for Biopesticide Manufacturers
The United States provides access to one of the world's largest agricultural economies and a sophisticated crop protection distribution system. Under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the EPA evaluates pesticides before they can be marketed. Its biopesticide framework includes three principal categories: microbial pesticides, biochemical pesticides and plant-incorporated protectants. Registration requirements differ according to product characteristics, but applicants must submit the information necessary for the agency to assess potential risks to human health and the environment.
For foreign manufacturers, the U.S. regulatory process can involve product chemistry, toxicological studies, manufacturing information, labeling and import compliance. Some products also require state-level registration before distribution. The EPA recommends that applicants consider pre-submission meetings to clarify the data requirements relevant to their technologies. A successful federal registration is an important commercial milestone, but it does not guarantee market adoption. Companies must also demonstrate consistent field performance, formulation stability and economic value to growers and distributors.
American corn, soybean, cotton and specialty crop producers face persistent challenges involving pest resistance, production costs and variable environmental conditions. Biological products may provide additional tools within integrated pest management programs, particularly when supported by reliable technical recommendations. Nevertheless, their effectiveness depends on the target pest, formulation, application timing and field conditions. For manufacturers, competitive pricing alone is insufficient: commercial success requires dependable supply chains, local agronomic support and evidence that a product can perform under practical farming conditions.
Field trials in U.S. soybean production help researchers evaluate emerging crop protection technologies under practical growing conditions before broader commercial adoption.
Brazil offers another major opportunity because of its agricultural scale and expanding biological input industry. The country's Bioinputs Law 15,070, enacted in December 2024, established a specific legal framework for biological agricultural technologies. According to MAPA, Brazil authorized 162 products classified as biological inputs during 2025, a historical high. The total includes different categories of biological products and should not be interpreted as 162 newly approved active ingredients. It nevertheless illustrates the increasing availability of these technologies and the competition facing suppliers seeking to enter the Brazilian market.
For international manufacturers, Brazil's soybean, corn, cotton, sugarcane and horticultural sectors offer multiple potential applications. However, product registration requires an understanding of the applicable categories, technical documentation and implementation of the country's regulatory framework. Microbial strain identification, formulation consistency, safety assessments and local efficacy data may influence regulatory and commercial outcomes. Companies must also consider how climatic conditions, storage requirements and pest pressure affect biological product performance across different agricultural regions.
Argentina's Regulatory Reforms Add a New Dimension to Regional Competition
While the United States and Brazil remain central to commercial expansion strategies, Argentina is seeking to strengthen its position as a regional agricultural biotechnology hub. Recent changes to its plant protection regulatory framework have created new expectations among manufacturers and technology developers. Argentina's National Service for Agri-Food Health and Quality (SENASA) introduced Resolution 458/2025, subsequently amended by Resolution 843/2025, with the updated framework taking effect in January 2026. The changes form part of an effort to modernize procedures and improve the regulatory environment for agricultural inputs, including biological products.
Agricultural biotechnology research in Argentina supports the country's efforts to strengthen scientific innovation and expand its role in Latin America's biological crop protection industry.
The Argentine framework includes provisions addressing regulatory convergence with selected foreign jurisdictions, including the United States and Brazil, under defined conditions. This could make the country more attractive to companies evaluating new registrations, local testing or commercial partnerships. However, regulatory modernization does not establish automatic approval for every imported biopesticide, nor does it demonstrate that registration times have already declined across all product categories. The effectiveness of the reforms will depend on their implementation, administrative capacity and the predictability of technical requirements.
Argentina's ambitions extend beyond product registration. Its agricultural research institutions, biotechnology companies and experience in major crop production provide a foundation for developing microbial formulations, conducting field trials and building manufacturing partnerships. In 2026, the country also opened a new application round under its biotechnology and nanotechnology investment-promotion regime. Becoming a regional biotechnology center will require sustained investment, scientific development and commercial execution, rather than regulatory changes alone.
Elsewhere in Latin America, Mexico has announced administrative simplification measures affecting certain low-risk pesticide categories, including biological products. Peru, Chile and Colombia maintain their own regulatory procedures for agricultural biological inputs. These markets may offer additional opportunities for international suppliers, but their requirements vary in product classification, documentation and registration pathways. Latin America remains a collection of distinct regulatory markets, making country-specific planning essential for companies pursuing regional expansion.
Scientific innovation is another factor reshaping competition. Predictive toxicology tools, including quantitative structure-activity relationship (QSAR) models, can help assess certain chemical properties during product development. However, these methods are not substitutes for microorganism identification, biological safety studies or the efficacy information required by regulators. Manufacturers developing microbial pesticides must pay particular attention to strain characterization, production consistency and potential differences in performance between laboratory and field conditions.
Microbial characterization and laboratory testing remain essential to biopesticide development, complementing predictive toxicology tools and supporting regulatory safety assessments.
Competition among manufacturers from North America, Europe, Asia and Latin America is likely to increase as biological crop protection technologies become more widely available. Yet a formulation developed for one agricultural environment may require additional trials before entering another. Temperature, humidity, microbial stability, application practices and local pest populations can all affect results. For companies entering the U.S. or Brazilian markets, regulatory approval must therefore be supported by local field validation, reliable distribution and technical assistance.
For growers, broader access to biopesticides could provide additional options for managing pests and diseases. But a larger number of registered products does not automatically translate into higher yields, lower production costs or improved environmental outcomes. Those benefits depend on product characteristics, appropriate use and the conditions under which technologies are deployed. Biological pesticides are valuable components of crop protection strategies when supported by sound agronomic evidence, rather than replacements for every conventional pesticide.
The United States and Brazil offer substantial opportunities for biopesticide manufacturers seeking international growth, combining agricultural scale with established or evolving regulatory systems. Argentina's reforms introduce another potential center for research, development and commercialization within Latin America. The next stage of market expansion will depend on how effectively manufacturers connect scientific innovation, regulatory compliance, local agronomic performance and commercial partnerships across increasingly competitive agricultural markets.
